Damien Roos-Weil Selected Research

Damien Roos-Weil Research Topics

Disease

15	Neoplasms (Cancer) 03/2024 - 01/2013
11	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 05/2014
6	Multiple Myeloma 11/2023 - 10/2011
5	Leukemia 03/2024 - 09/2014
5	Progressive Multifocal Leukoencephalopathy 12/2023 - 01/2020
5	Lymphoma (Lymphomas) 10/2023 - 01/2018
5	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 11/2020
5	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023 - 04/2015
4	Infections 04/2024 - 07/2011
2	Communicable Diseases (Infectious Diseases) 04/2024 - 01/2022
2	Nocardia Infections 04/2024 - 01/2022
2	Aspergillosis 03/2024 - 03/2014
2	Paraproteinemias (Monoclonal Gammopathy) 10/2023 - 11/2020
2	Erdheim-Chester Disease 01/2022 - 01/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 01/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 02/2016
2	Histiocytosis 01/2017 - 01/2017
2	Diarrhea 05/2014 - 07/2011
1	Prolymphocytic Leukemia 01/2024
1	Liver Diseases (Liver Disease) 12/2023
1	Renal Insufficiency (Renal Failure) 11/2023
1	Multiple Sclerosis 11/2023
1	Angioedema 10/2023
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2023
1	B-Cell Prolymphocytic Leukemia 01/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Inflammation (Inflammations) 01/2023
1	COVID-19 11/2022
1	Fibrosis (Cirrhosis) 10/2022
1	Encephalitis (Encephalitis, Rasmussen) 01/2022
1	VEXAS syndrome 11/2021
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2021
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021
1	Ophthalmoplegia (External Ophthalmoplegia) 11/2020
1	Ataxia (Dyssynergia) 11/2020
1	Neurologic Manifestations (Neurological Manifestations) 11/2020
1	Acute Kidney Injury (Acute Renal Failure) 10/2020

Drug/Important Bio-Agent (IBA)

4	ibrutinibIBA 03/2024 - 01/2018
3	Rituximab (Mabthera)FDA Link 03/2024 - 08/2021
3	venetoclaxIBA 01/2024 - 01/2021
3	Immune Checkpoint InhibitorsIBA 01/2023 - 07/2021
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 05/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 01/2013
3	Alemtuzumab (Campath)FDA Link 01/2021 - 03/2014
2	pembrolizumabIBA 12/2023 - 11/2023
2	Melphalan (Alkeran)FDA LinkGeneric 11/2023 - 01/2019
2	AntibodiesIBA 10/2023 - 11/2020
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
2	Messenger RNA (mRNA)IBA 11/2022 - 01/2018
2	carfilzomibIBA 01/2022 - 01/2019
2	Lenalidomide (CC 5013)FDA Link 12/2020 - 01/2019
2	Bortezomib (Velcade)FDA Link 12/2020 - 10/2020
2	Vincristine (Oncovin)FDA LinkGeneric 01/2020 - 12/2019
2	Prednisone (Sone)FDA LinkGeneric 12/2019 - 01/2019
2	Peptides (Polypeptides)IBA 10/2019 - 01/2018
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2019 - 11/2018
2	EnzymesIBA 01/2019 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2017
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024
1	Bendamustine Hydrochloride FDA Link 03/2024
1	acalabrutinibIBA 03/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2023
1	fludarabineIBA 11/2023
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	VaccinesIBA 11/2022
1	2019-nCoV Vaccine mRNA-1273IBA 11/2022
1	BNT162 VaccineIBA 11/2022
1	Antiviral Agents (Antivirals)IBA 10/2022
1	CytokinesIBA 08/2022
1	Chimeric Antigen ReceptorsIBA 08/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Azacitidine (5 Azacytidine)FDA Link 11/2021
1	idelalisibIBA 11/2021
1	obinutuzumabIBA 11/2021
1	NucleosidesIBA 01/2021
1	ruxolitinibIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2020
1	EpitopesIBA 11/2020
1	cold agglutininsIBA 11/2020
1	Immunoglobulin M (IgM)IBA 11/2020
1	ParaproteinsIBA 11/2020
1	GangliosidesIBA 11/2020
1	NivolumabIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	trametinibIBA 01/2020

Therapy/Procedure

12	Therapeutics 03/2024 - 05/2014
9	Transplantation 04/2024 - 01/2013
6	Drug Therapy (Chemotherapy) 10/2023 - 01/2013
6	Hematopoietic Stem Cell Transplantation 07/2023 - 01/2011
4	Stem Cell Transplantation 11/2023 - 10/2011
2	Cell Transplantation 04/2024 - 01/2022
2	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2022 - 10/2021
1	Liver Transplantation 10/2022
1	Immunotherapy 08/2022